Analysis of three effective methods for treating rectal cancer

Rectal cancer is a tumor disease with a certain degree of heredity. Many patients with rectal cancer have a family history of cancer, which seriously harms their health. So what are the common methods of treating rectal cancer ? Here are some common methods of treating rectal cancer.

In general, the common treatments for rectal cancer are:

1. Chemotherapy: It is mostly used as an adjuvant therapy before and after rectal cancer surgery. This method of treating rectal cancer before rectal cancer surgery cannot improve the patient's survival rate, but it can reduce the tumor to a certain extent, which is conducive to surgical resection and preservation of sphincter function and can reduce the chance of tumor spread during and after surgery. Many studies have shown that the use of sufficient combined chemotherapy after surgery can improve the patient's survival rate. However, since most patients are weak after surgery and cannot tolerate the toxic side effects of chemotherapy, it is often combined with biological immunotherapy in clinical practice to reduce its toxic side effects.

2. Radiotherapy: It is also a common method for treating rectal cancer. Radiotherapy for rectal cancer should be used with caution. Not only should its efficacy on the cancer lesions be considered, but also its damage to the adjacent organs around the rectum should be considered. In clinical practice, it is generally only used as an adjuvant treatment for rectal cancer surgery. It has certain contraindications and should be used with caution by patients with poor physical constitution. In clinical practice, it is often combined with biological immunotherapy to reduce its toxic side effects.

3. Surgical treatment: It is the first choice for early-stage rectal cancer treatment, and the treatment effect is obvious. This method of treating rectal cancer can also be used for patients in the middle and late stages who do not have surgical contraindications. It can remove the metastatic lesions of rectal cancer, but the effect is not ideal. Whether it is early or late-stage rectal cancer, surgical treatment is prone to recurrence and metastasis. Postoperative combined biological immunotherapy, using autoimmune cells for anti-cancer treatment, can effectively consolidate the surgical effect and effectively prevent cancer metastasis and recurrence.

The above is an introduction to the common methods of treating rectal cancer. I believe everyone has some understanding of this. Patients should choose the method of treating rectal cancer that suits them according to their actual condition and should not choose blindly.